ARTICLE
Auteur(s) : Carmelo
Schepis, Maddalena Siragusa
Oasi Institute (IRCCS), Unit of Dermatology, Via Conte
Ruggero, 73, 94018 Troina, Italy
Tuberous Sclerosis Complex (TCS) is a neurocutaneous syndromic
disorder which affects skin, the central nervous system, the heart,
kidney, lung and other sites of the human body. It is an autosomal
dominant genetic condition related to two tumour suppressor genes
located on chromosome 9 or chromosome 16 [1].
Cutaneous manifestations of TSC are considered to be part of the
major features required for its diagnosis [1]. Among skin features,
facial angiofibromas (FA) develop at approximately the age of
5 and become more evident with age. At first, FA are small
pink or red papules, mostly located on the cheeks, nasolabial
folds, nose and chin. After puberty they grow, may bleed and often
cause discomfort for patients and their parents. For this reason,
various modalities of treatment have been adopted: laser [2]
dermoabrasion, electrosurgery and, recently, application of a
tincture of podophyllin [3], or photodynamic therapy followed by
pulsed dye laser [4]. These treatments, if repeated, result in
acceptable cosmetic results. All surgical methods need previous
local anaesthesia consisting of regional nerve block or EMLA
application under occlusion over the affected area. Sometimes,
general anaesthesia has been required. Only cryotherapy among the
different surgical techniques, can be used without previous
anaesthesia.
For this reason we recently treated two women, affected by TSC
and aged 35 and 17, with cryosurgery, using the liquid
nitrogen spray gun CRY-AC. They came to our observation with a
request for a cosmetic improvement of their facial appearance. Both
presented a very mild mental disability and had pharmacologically
controlled epileptic seizures.
For surgical treatment, the thinnest nozzles were used to emit
an open spray of liquid nitrogen and the application was repeated
after an interval of some minutes. Both patients accepted easily
the interventions and only referred to a mild burning sensation
during the application and for some minutes after, together with a
mild reddish color of the treated areas, which lasted for less than
one hour. Both patients improved after a series of repeated
treatments and reported feeling satisfied with the results of the
therapy. The older patient, treated every 45 days, from autumn
to spring for two years, obtained a dramatic improvement after ten
applications (figures
1A, B). The younger had a less important, but good, benefit
too after four applications.
Cryotherapy is anecdotally cited in the treatment of FA in
patients with TSC; however, this method is barely documented for FA
[5]. On the other hand, it is widely used in dermatology to destroy
several types of benign lesion [6]. In our recent experience, we
found it easy to apply and not requiring local anaesthesia with
EMLA or regional nerve blocks because its administration produces
only an initial mild pain that disappears in a few minutes. Thus,
in selected patients, like the two treated by us, such a method
does not need hospitalization or day surgery. In our experience, it
is both effective and efficient, very cheap, easy to administer,
convenient for the patients and repeatable from time to time,
according to the clinical evolution. The side effects are minimal
and predictable; moreover it can be used in parallel to other
treatments currently available, such as lasers, in case of failure.
However, additional experience is needed to reach a definitive
opinion.
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Schwartz RA, Fernández G, Kotulska K,
Józwiak S. Tuberous sclerosis complex: Advances in diagnosis,
genetics, and management. J Am Acad Dermatol 2007; 57: 189-202.
2 Kaufman AJ, Grekin RC, Geisse JK,
Frieden IJ. Treatment of adenoma sebaceum with the copper
vapour laser. J Am Acad Dermatol 1995; 33: 770-4.
3 Türkmen M, Ertam I, Ünal I, Dereli T.
Facial angiofibromas of Tuberous Sclerosis: successful tretment
with podophyllin. JEADV 2009; 23: 713-4.
4 Weinberger CH, Endrizzi B, Hook KP, Lee P.
Treatment of Angiofibromas of Tuberous Sclerosis with
5-Aminolevulinic acid blue light photodynamic therapy followed by
immediate pulsed dye laser. Dermatol Surg 2009; 35: 1849-51.
5 Duir E, Hirshowitz B. The use of cryosurgery in
treating the fibrous papules of Tuberous Sclerosis. Ann Plast Surg
1980; 4: 158-60.
6 Thai K-E, Sinclair RD. Cryosurgery of benign skin
lesions. Australas J Dermatol 1999; 40: 175-86.
|